Robert Azelby - 29 Jun 2026 Form 4 Insider Report for Autolus Therapeutics plc (AUTL)

Reporting relationship: Director
Issuer ticker: AUTL
Reported as of: 29 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 16:07:04 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Azelby

Key filing fact

Robert Azelby filed Form 4 for Autolus Therapeutics plc (AUTL) on 01 Jul 2026.

Key facts

This page summarizes Robert Azelby's Form 4 filing for Autolus Therapeutics plc (AUTL).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 16:07.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001656998 Primary reporting owner

Azelby Robert

Relationship: Director
Address: THE MEDIAWORKS, WHITE CITY, C/O AUTOLUS THERAPEUTICS PLC, LONDON, UNITED KINGDOM
Signature: /s/ Robert Azelby
Signature date: 01 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AUTL transaction Derivative

Restricted Share Units

Award

Transaction value
Shares: +31,667
Change %
Price: $0.000000^*
Shares after: 31,667
Date: 29 Jun 2026
Ownership: Direct
Underlying class: American Depositary Shares
Underlying amount: 31,667
Exercise price
Footnotes: F1, F2

AUTL transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +47,500
Change %
Price: $0.000000^*
Shares after: 47,500
Date: 29 Jun 2026
Ownership: Direct
Underlying class: American Depositary Shares
Underlying amount: 47,500
Exercise price: $1.61
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.

Footnote F2

The RSUs vest in one installment on June 29, 2027.

Footnote F3

Share options vest in twelve equal monthly installments commencing on July 29, 2026.